Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guntram Büsche

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Leukemia Research|July 21, 2009
Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndromeKais Hussein, Katharina Theophile, Guntram Büsche, et al.
European Journal of Haematology|January 18, 2021
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progressionStephan Bartels, Julia Vogtmann, Elisa Schipper, et al.
Leukemia & Lymphoma|May 27, 2004
Analysis of risk factors of the evolution of myelofibrosis in pre-fibrotic chronic idiopathic myelofibrosis: a retrospective study based on follow up biopsies of 70 patients by using the RECPAM methodAndreas Kreft, Birgitt Wiese, Martin Weiss, et al.
British Journal of Haematology|June 29, 2005
Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerinOliver Bock, Gero Loch, Ulrika Schade, et al.
British Journal of Haematology|July 17, 2009
Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosisOliver Bock, Michaela Muth, Katharina Theophile, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2020
Feasibility of Combined Detection of Gene Mutations and Fusion Transcripts in Bone Marrow Trephines from Leukemic NeoplasmsStephan Bartels, Britta Hasemeier, Julia Vogtmann, et al.
Cancer Medicine|January 13, 2019
Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemiaMuhammad Faisal, Helge Stark, Guntram Büsche, et al.
Cancer Genetics and Cytogenetics|May 19, 2005
BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinibDorothea Gadzicki, Nils von Neuhoff, Doris Steinemann, et al.
Experimental Hematology|July 21, 2009
JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosisKais Hussein, Oliver Bock, Katharina Theophile, et al.
Annals of Hematology|July 14, 2010
Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemiaMichaela Muth, Bianca M Engelhardt, Nicolaus Kröger, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Leukemia Research|July 21, 2009
Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndromeKais Hussein, Katharina Theophile, Guntram Büsche, et al.
European Journal of Haematology|January 18, 2021
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progressionStephan Bartels, Julia Vogtmann, Elisa Schipper, et al.
Leukemia & Lymphoma|May 27, 2004
Analysis of risk factors of the evolution of myelofibrosis in pre-fibrotic chronic idiopathic myelofibrosis: a retrospective study based on follow up biopsies of 70 patients by using the RECPAM methodAndreas Kreft, Birgitt Wiese, Martin Weiss, et al.
British Journal of Haematology|June 29, 2005
Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerinOliver Bock, Gero Loch, Ulrika Schade, et al.
British Journal of Haematology|July 17, 2009
Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosisOliver Bock, Michaela Muth, Katharina Theophile, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2020
Feasibility of Combined Detection of Gene Mutations and Fusion Transcripts in Bone Marrow Trephines from Leukemic NeoplasmsStephan Bartels, Britta Hasemeier, Julia Vogtmann, et al.
Cancer Medicine|January 13, 2019
Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemiaMuhammad Faisal, Helge Stark, Guntram Büsche, et al.
Cancer Genetics and Cytogenetics|May 19, 2005
BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinibDorothea Gadzicki, Nils von Neuhoff, Doris Steinemann, et al.
Experimental Hematology|July 21, 2009
JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosisKais Hussein, Oliver Bock, Katharina Theophile, et al.
Annals of Hematology|July 14, 2010
Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemiaMichaela Muth, Bianca M Engelhardt, Nicolaus Kröger, et al.
Pageof 6